Balloon valvuloplasty as percutaneous intervention for pulmonary stenosis: Experience from a tertiary care center
| Title: | Balloon valvuloplasty as percutaneous intervention for pulmonary stenosis: Experience from a tertiary care center |
|---|---|
| Authors: | Jaywant Navale, Nikhil Borikar, Ajay Chaurasia, Parag Bawaskar, Kiran Narang, Chetan Bhandarkar, Kondaveeti Thirupathi Rao, Gayatri Autkar |
| Source: | International Journal of the Cardiovascular Academy, Vol 8, Iss 2, Pp 46-52 (2022) |
| Publisher Information: | Galenos Publishing House, 2022. |
| Publication Year: | 2022 |
| Collection: | LCC:Diseases of the circulatory (Cardiovascular) system |
| Subject Terms: | balloon valvuloplasty, congenital heart disease, echocardiography, pulmonary regurgitation, pulmonary valve stenosis, pulmonary valve, Diseases of the circulatory (Cardiovascular) system, RC666-701 |
| More Details: | Background: To assess immediate and intermediate outcomes of percutaneous balloon pulmonary valvuloplasty (BPV) in children and adults. Materials and Methods: This retrospective, single-center study included patients who had undergone balloon valvuloplasty for the treatment of moderate to severe pulmonary stenosis at a tertiary care center in India between May 2011 and July 2018. Clinical profile, echocardiographic details, procedural details, complications, short term, and intermediate results were assessed. Results: A total of 43 patients were assessed. The mean age of the study population was 13.87 ± 11.71 years. Of them, 21 (48.8%) patients were men and 30 (69.8%) patients were children/adolescents. Single-balloon technique was used in all the cases. Balloon/annulus ratio was 1.28 ± 0.04. Immediate procedural success (Group 1) and partial procedural success (Group 2) were achieved in 26 (60.5%) and 17 (39.5%) patients, respectively. The right ventricular systolic pressure reduced from 117.70 ± 31.77 mmHg to 53.56 ± 13.29 mmHg postprocedure (P < 0.001). Peak-to-peak transvalvular gradient reduced from 102.81 ± 31.66 mmHg to 35.56 ± 12.47 mmHg postprocedure (P < 0.001). Intermediate follow-up was conducted for 2.61 ± 0.75 years (range: 2–4 years). At intermediate follow-up, peak-to-peak instantaneous gradient was 27.21 ± 5.80 mmHg. Restenosis, moderate, and severe pulmonary regurgitation were reported in 2 (7.1%), 4 (14.3%), and 2 (7.1%) patients, respectively. Conclusion: Percutaneous BPV is a safe and efficacious procedure for the treatment of moderate to severe pulmonary valve stenosis in children and adults. The procedure had excellent immediate and intermediate follow-up results. |
| Document Type: | article |
| File Description: | electronic resource |
| Language: | English |
| ISSN: | 2405-8181 2405-819X |
| Relation: | http://www.ijcva.com/article.asp?issn=2405-8181;year=2022;volume=8;issue=2;spage=46;epage=52;aulast=Navale; https://doaj.org/toc/2405-8181; https://doaj.org/toc/2405-819X |
| DOI: | 10.4103/ijca.ijca_56_21 |
| Access URL: | https://doaj.org/article/79943fad05c84b0ab7e470ed0d3e0c17 |
| Accession Number: | edsdoj.79943fad05c84b0ab7e470ed0d3e0c17 |
| Database: | Directory of Open Access Journals |
| ISSN: | 24058181 2405819X |
|---|---|
| DOI: | 10.4103/ijca.ijca_56_21 |
| Published in: | International Journal of the Cardiovascular Academy |
| Language: | English |